ICD-10 Coding for Adrenal Nodule(C74.01, C74.01U, C74.02)
Explore detailed ICD-10 coding guidelines for adrenal nodules, including benign and malignant classifications, documentation requirements, and common coding pitfalls.
Complete code families applicable to Adrenal Nodule
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E27.8 | Other specified disorders of adrenal gland | Use for non-neoplastic adrenal disorders such as hyperplasia. |
|
| D35.0 | Benign neoplasm of adrenal gland, unspecified | Use for benign adrenal tumors when laterality is not specified. |
|
| D35.01 | Benign neoplasm of right adrenal gland | Use for benign tumors of the right adrenal gland. |
|
| D35.02 | Benign neoplasm of left adrenal gland | Use for benign tumors of the left adrenal gland. |
|
| C74.9 | Malignant neoplasm of adrenal gland, unspecified | Use for confirmed malignant adrenal tumors. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdrenal Nodule
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adrenal Nodule.
Omitting CT attenuation values in documentation
Impact
Clinical: Inability to accurately assess nodule characteristics., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient documentation.
Mitigation
Ensure radiology reports include HU values, Train staff on documentation requirements
Using E27.8 for neoplastic nodules
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on neoplasm prevalence.
Mitigation
Use D35.0x for benign neoplasms with documentation of 'adenoma' or 'benign neoplasm'.
Not specifying laterality for benign neoplasms
Impact
Reimbursement: Claims may be denied due to lack of specificity., Compliance: Failure to comply with laterality coding requirements., Data Quality: Loss of data specificity for laterality.
Mitigation
Use D35.01 for right and D35.02 for left adrenal neoplasms.
Laterality coding
Impact
Failure to specify laterality can result in audit findings.
Mitigation
Ensure all documentation specifies laterality for adrenal neoplasms.